Super Lizer use in AV fistula creation

The effect of stellate ganglion light irradiation using Super Lizer in arteriovenous fistula creation for hemodialysis: a pilot study

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1032230550

Enrollment

Registered

2024-01-10

Start date

2024-01-24

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage kidney disease

Interventions

Near-infrared light

1. The researchers explain the study to the patient and obtain informed consent during the preoperative outpatient visit. Fistula creation site, either in the forearm or the upper arm, is determined a

Super Lizer

Stellate ganglion

Stellate Ganglion Light Irradiation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who are scheduled for arteriovenous fistula creation for hemodialysis. 2. Patients who have a sufficient understanding of the research and provide consent. 3. Patients who are 18 years of age or older at the time of obtaining consent.

Exclusion criteria

Exclusion criteria: 1. Patients with arterial vessel diameter at the planned arteriovenous fistula site of 1.5mm or less. 2. Patients with venous vessel diameter at the planned arteriovenous fistula site of 2mm or less after tourniquet 3. Patients with significant arterial sclerosis at the planned arteriovenous fistula site. 4. Patients with glaucoma. 5. Patients with cataracts. 6. Patients with BMI >= 35. 7. Patients with skin disorders at the planned irradiation site. 8. Patients who are considered unsuitable for participation in this study by the attending physician.

Design outcomes

Primary

Measure	Time frame
The difference/change rate in vein diameter with the use of tourniquet before and after stellate ganglion light irradiation (mm/%): A) Creation site in the forearm: Cephalic vein at the wrist. B) Creation site in the upper arm: Cephalic vein at the elbow.	—

Secondary

Measure	Time frame
1. The difference/change rate in arterial vessel diameter before and after stellate ganglion light irradiation (mm/%): A) Creation site in the forearm: Radial artery at the wrist. B) Creation site in the upper arm: Radial artery at the elbow. C) Creation site in the upper arm using the brachial artery (upstream of the radial artery): Brachial artery. 2. The blood flow in the brachial artery immediately after surgery. 3. The pain VAS (Visual Analogue Scale) immediately after surgery. 4. Surgical duration. 5. The change of the planned fistula creation site from upper arm to forearm. 6. The fistula patency rate at 1 month: Confirmed by fistula sound, thrill, and ultrasound.	—

Measure

Time frame

1. The difference/change rate in arterial vessel diameter before and after stellate ganglion light irradiation (mm/%): A) Creation site in the forearm: Radial artery at the wrist. B) Creation site in the upper arm: Radial artery at the elbow. C) Creation site in the upper arm using the brachial artery (upstream of the radial artery): Brachial artery. 2. The blood flow in the brachial artery immediately after surgery. 3. The pain VAS (Visual Analogue Scale) immediately after surgery. 4. Surgical duration. 5. The change of the planned fistula creation site from upper arm to forearm. 6. The fistula patency rate at 1 month: Confirmed by fistula sound, thrill, and ultrasound.

—

Contacts

Public ContactZhuan Jin

Kameda Medical Center

jin.zhuan@kameda.jp+81-4-7092-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026